NCT02526498 - Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

July 15, 2015

Primary Completion Date

August 18, 2017

Study Completion Date

March 31, 2021

Conditions

Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast CarcinomaProgesterone Receptor PositiveStage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer

Interventions

RADIATION

Accelerated Partial Breast Irradiation

Undergo accelerated partial breast irradiation (APBI) using high-dose rate (HDR) brachytherapy

RADIATION

High-Dose Rate Brachytherapy

Undergo APBI using HDR brachytherapy

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (10)

10457

21st Centry Oncolgy, Yonkers

10461

Montefiore Medical Center, The Bronx

19010

Bryn Mawr Hospital, Bryn Mawr

44106

Cleveland Clinic, Cleveland

48073

William Beaumont Hospital Research Institute, Royal Oak

84112

Huntsman Cancer Hospital, University of Utah, Salt Lake City

85297

Arizona Breast Cancer, Gilbert

92093

University of California, San Diego, La Jolla

08901

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

08903

Rutgers Cancer Institute of New Jersey, New Brunswick